Experiment 1227408
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | KAHN,JO: KAPLAN,LD: GAMBERTOGLIO,JG: BREDESEN,D: ARRI,CJ: TURIN,L: KOBORT,T: WILLIAMS,RL: LIFSON,JD: VOLBERDING,PA:. (1990). THE SAFETY AND PHARMACOKINETICS OF GLQ223 IN SUBJECTS WITH AIDS AND AIDS-RELATED COMPLEX: A PHASE I STUDY.. 4(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | PLASMA CLEARANCE RANGED FROM 11.O L/H TO 6.7 L/H FOR DOSES RANGING FROM 8 TO 36 MCG/KG. THE MAXIMAL PLASMA CONCENTRATION WAS 876+/- 60MCG/KG AT THE 36 MCG/KG DOSE LEVEL. THE HALF-LIFE RANGED FROM 2.4-4.3 HOURS FOR DOSES OF 8-36 MCG/KG. |
| Dose amount | 8-36 MCG |
| Number | 2 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | ML |
| Dose expression | DOSE |